Share

Recommendation Update: Use of Tocilizumab, Sarilumab and Baricitinib in Treatment of Hospitalized Covid + Patients When Supply of These Drugs is Limited.

Posted on: October 13, 2021

This document explains how tocilizumab, sarilumab and baricitinib  for treatment of hospitalized Covid+ patients is in very limited supply in Canada. The Recommendation for BC Health Authorities to use these in a priority sequence depending on supply availability. 

IH

Use of Tocilizumab, Sarilumab and Baricitinib